Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ABIONYX Pharma logo — A New Generation Biotech Company

ABIONYX Pharma

A New Generation Biotech Company

Founded 2019 France France 8 employees Grant Total: $140.00M Biotechnology, Health Care

General Information

Company Name ABIONYX Pharma
Founded Year 2019
Location France France
Employees 8
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with ABIONYX Pharma. To contact ABIONYX Pharma, visit abionyx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ABIONYX Pharma

ABIONYX Pharma, a New Generation Biotech Company, was founded in 2005 in France. The company is dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. Having its focus on the Biotechnology and Health Care industries, ABIONYX Pharma recently received a €1.00M grant investment on 14 March 2024 from Bpifrance. ABIONYX Pharma's commitment to addressing unmet medical needs presents potential opportunities for growth and impact in the biotech and healthcare sectors.

Taxonomy: biotech, pharmaceuticals, drug development, innovation, therapy discovery, treatment, biomedical research, biopharmaceuticals, medical advancements

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €1.00M 1
Bpifrance
Bpifrance
14 Mar 2024
Post IPO Equity €5.00M -
17 Nov 2021
Series C €50.00M 9
Alta Partners Daiwa Corporate Investment HealthCap
Alta Partners, Daiwa Corporate Investment +7
25 Jul 2010
Series B $53.50M -
12 Nov 2006
Series A $30.50M -
22 Aug 2005

ABIONYX Pharma Alternatives & Competitors

View All Alternatives
ABIONYX Pharma vs
R2M Pharma, Inc.
R2M Pharma, Inc. United States

R2M is a collaborative pharmaceutical company that works with you throughout the discovery and devel...

17 employees
Biotechnology, Health Care
ABIONYX Pharma vs
ADC Biotechnology
ADC Biotechnology

Accelerating solutions for developers to overcome conjugation challenges, making new ADC-based anti-...

Venture round
Biopharma, Biotechnology
ABIONYX Pharma vs
Soricimed Biopharma Inc.
Soricimed Biopharma Inc. Canada

Dedicated to developing effective and novel targeted treatments for cancer.

Grant
12 employees
Biopharma, Biotechnology
View all alternatives

FAQ About ABIONYX Pharma

A New Generation Biotech Company
ABIONYX Pharma was founded in 2019.
ABIONYX Pharma is headquartered in France.
ABIONYX Pharma operates in Biotechnology and Health Care. Its work centres on biotech, pharmaceuticals, drug development and innovation.
ABIONYX Pharma has approximately 8 employees.
ABIONYX Pharma has completed 5 funding rounds, raising a total of $140.00M. The latest funding stage is Grant.
Top alternatives and competitors to ABIONYX Pharma include R2M Pharma, Inc., ADC Biotechnology, Soricimed Biopharma Inc., BIOCAD, Analytica Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ABIONYX Pharma and R2M Pharma, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ABIONYX Pharma, https://bouncewatch.com/company/abionyx-pharma, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes